GLP-1 Studies Suggest Benefits Extend to Infectious Diseases

(MedPage Today) -- Recent studies suggest that people with type 2 diabetes on GLP-1 receptor agonists were less likely to develop tuberculosis (TB) or be hospitalized or die from infections. In an international study of more than 7 million people...